Quick Answer
iBio, Inc. reported Net Income Loss of -$18.38 million for the year ending 2025.
- iBio, Inc. showed an increase of +26.2% in Net Income Loss from 2024 to 2025.
- This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on September 5, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: -$2.82 million | Q4 2010: -$4.71 million | Q1 2011: -$3.03 million | Q3 2011: $383.1 thousand | Q4 2011: -$1.60 million | Q1 2012: -$3.10 million | Q3 2012: -$2.05 million | Q4 2012: -$1.07 million | Q1 2013: -$1.76 million | Q3 2013: $379.0 thousand | Q4 2013: -$1.63 million | Q1 2014: -$1.28 million | Q3 2014: -$1.41 million | Q4 2014: -$1.65 million | Q1 2015: -$1.68 million | Q3 2015: -$1.81 million | Q4 2015: -$2.25 million | Q1 2016: -$3.04 million | Q3 2016: -$3.06 million | Q4 2016: -$3.23 million | Q1 2017: -$3.91 million | Q3 2017: -$3.83 million | Q4 2017: -$3.90 million | Q1 2018: -$3.96 million | Q3 2018: -$4.40 million | Q4 2018: -$4.47 million | Q1 2019: -$4.22 million | Q3 2019: -$4.46 million | Q4 2019: -$3.76 million | Q1 2020: -$4.68 million | Q3 2020: -$7.53 million | Q4 2020: -$8.13 million | Q1 2021: -$7.66 million | Q3 2021: -$8.94 million | Q4 2021: -$11.92 million | Q1 2022: -$12.39 million | Q3 2022: -$18.13 million | Q4 2022: -$33.55 million | Q1 2023: -$7.29 million | Q3 2023: -$5.75 million | Q4 2023: -$8.21 million | Q1 2024: -$3.17 million | Q3 2024: -$3.99 million | Q4 2024: -$4.36 million | Q1 2025: -$4.86 million | Q3 2025: -$5.72 million | Q4 2025: -$8.99 million.
- Over the full 14 years of available data (2012 to 2025), iBio, Inc.'s Net Income Loss has declined by 223.8%.
- Historical annual values: Fiscal year 2025: -$18.38 million | Fiscal year 2024: -$24.91 million | Fiscal year 2023: -$65.01 million | Fiscal year 2022: -$50.30 million | Fiscal year 2021: -$23.21 million | Fiscal year 2020: -$16.44 million | Fiscal year 2019: -$17.59 million | Fiscal year 2018: -$16.11 million | Fiscal year 2017: -$14.53 million | Fiscal year 2016: -$9.76 million | Fiscal year 2015: -$6.63 million | Fiscal year 2014: -$3.67 million | Fiscal year 2013: -$6.20 million | Fiscal year 2012: -$5.68 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: